Efficacy and safety of tofacitinib for the treatment of moderate-to-severe ulcerative colitis in biologic-naive patients. Liatsos C, Tzouvala M, Michalopoulos G, Giouleme O, et al. Eur J Gastroenterol Hepatol 2025 Jan 23. doi: 10.1097/MEG.0000000000002926.

Read + Share

Amedeo Smart

Independent Medical Education

Liatsos C, Tzouvala M, Michalopoulos G, Giouleme O, et al. Efficacy and safety of tofacitinib for the treatment of moderate-to-severe ulcerative colitis in biologic-naive patients. Eur J Gastroenterol Hepatol 2025 Jan 23. doi: 10.1097/MEG.0000000000002926.
PMID: 39976073